Medicine recalls
|
| |
| Recall of Famotidina Cinfa Tablet 20mg |
| |
The Department of Health (DH) today (November 24) endorsed a licensed drug wholesaler, Reich Pharm Limited (Reich), to recall all batches of Famotidina Cinfa Tablet 20mg (Hong Kong Registration number HK-51630) from the market because the product’s label does not match with the registered one.
In the course of routine market surveillance by the DH, it was found that the label of the above product on minor information was different from the registered label, which rendered the product unregistered. Since supply of unregistered pharmaceutical product contravenes the Pharmacy and Poisons Regulations (Cap. 138A), Reich voluntarily recalls the product from the market. DH's investigation is continuing.
The above product, containing famotidine, is an over-the-counter product used for treatment and prevention of stomach ulcer. According to Reich, the product has been supplied to local community pharmacies only.
So far, the DH has not received any adverse drug reaction report related to the affected product.
Reich has set up a hotline (2470 1927) to answer related enquiries. The DH will closely monitor the recall.
Ends/Wednesday, 24 November , 2021
|
| |
